MCM
PLSE icon

MAI Capital Management’s Pulse Biosciences PLSE Stock Holding History

MAI Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7
Closed -$152 – 4009
2026
Q1 		$152 Buy
+7
New +$129 ﹤0.01% 4676

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

MAI Capital Management's PLSE Position: Q2 2026 in Review

MAI Capital Management sold out of Pulse Biosciences (PLSE) in Q2 2026, closing a stake of 7 shares — an estimated $152 sold.

MAI Capital Management first reported a position in PLSE in Q1 2026 and held it in 1 quarter. The position peaked at $152 in Q1 2026. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • MAI Capital Management reported no remaining Pulse Biosciences position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 7 Pulse Biosciences shares in Q2 2026, an estimated $152.
  • MAI Capital Management first reported a position in Pulse Biosciences in Q1 2026 and held it in 1 quarter.
  • MAI Capital Management's Pulse Biosciences position peaked at $152 in Q1 2026.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.